Millions of adults are continuing their education by returning to school and enrolling in credit and non-credit courses, certificates, micro-credentials, job training and degree programs.

─ Will feature discussion and insights from Fred Grossman, D.O., FAPA; Stanley Appel, M.D.; and James Berry, M.D., MPH — accomplished physicians specializing in ...

The challenge fee is non-refundable Objections will not be accepted after February 6, 2026 (11:50 pm) Challenges can be submitted only through online mode No individual candidate will be informed ...

TL;DR: Konami confirms development of a brand-new Silent Hill game alongside a Silent Hill 1 remake by Bloober Team, expanding its horror franchise revival. The publisher hints at more multi-platform ...

Jumble has been entertaining folks since 1954 and has been a classic game where scrambled words require you to unscramble them in order to find key letters that leads to a final word to be unscrambled ...

A large, multidisciplinary team led by researchers from Texas A&M University has made a potentially game-changing discovery about the development of devastating motor neuron diseases like amyotrophic ...

Twitch Drops, Patch 13, and a new system for sharing creations are on the horizon. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

Forbes contributors publish independent expert analyses and insights. I write about TV shows, movies, video games, entertainment & culture. Welcome, dearest Wordlers, to the year 2026. It’s a brand ...

The biggest stories of the day delivered to your inbox.

Emily Long is a freelance writer based in Salt Lake City. After graduating from Duke University, she spent several years reporting on the federal workforce for Government Executive, a publication of ...

Scroll down for hints and conversation about the puzzle for Thursday, Jan. 1, 2026. By New York Times Games Good morning, dear connectors. Welcome to today’s Connections forum, where you can give and ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the presentation of early safety and tolerability data from its Phase 1 ...